Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Medisure Laboratories Pakistan Pvt Ltd

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi-based pharmaceutical manufacturer with sterile and non-sterile manufacturing operations.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date21 Oct 2025Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Medisure Laboratories Pakistan (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
A-115, S.I.T.E., Super Highway, Karachi, Pakistan
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000503 Medisure Laboratories Pakistan (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000503 122 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx123public portfolio records represented
REG113unique registrations represented
IDX120indexed MedInfoBase presentations
SRC3additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR115current validated price records
G56generic molecules in indexed catalogue
DF9dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage93%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage93%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMedisure Laboratories Pakistan Pvt LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 23 Sep 2026Anti-infectives63 · 53%CNS & mental health23 · 19%Gastrointestinal & hepatology11 · 9%Cardiovascular8 · 7%Hematology & thrombosis7 · 6%Endocrine & metabolic2 · 2%Pain & musculoskeletal2 · 2%Other therapeutic areas4 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMedisure Laboratories Pakistan Pvt LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 23 Sep 2026120presentationsTablet60 · 50%Injection27 · 23%Capsule10 · 8%Cream6 · 5%Infusion6 · 5%Suspension5 · 4%Other forms6 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionMedisure Laboratories Pakistan Pvt LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 23 Sep 2026111comparable productsBelow peer median93 · 84%Near peer median11 · 10%Above peer median7 · 6%Company median price position-20.0%Lowest-price equivalents14Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMedisure Laboratories Pakistan Pvt LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,40 shared71% overlapMediate Pharmaceutical Pvt Ltd39 shared70% overlapNeutro Pharma (Pvt.) Ltd.,37 shared66% overlapZafa Pharmaceutical Laboratories (P…35 shared63% overlapBio-Labs(Pvt) Ltd35 shared63% overlapEpharm Laboratories35 shared63% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives63 products · 53%
CNS & mental health23 products · 19%
Gastrointestinal & hepatology11 products · 9%
Cardiovascular8 products · 7%
Hematology & thrombosis7 products · 6%
Endocrine & metabolic2 products · 2%
Pain & musculoskeletal2 products · 2%
Oncology & immunology2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins21 products · 18%
Antiepileptics13 products · 11%
Antipsychotics8 products · 7%
Fluoroquinolone antibacterials7 products · 6%
Macrolide antibacterials7 products · 6%
Antimalarials6 products · 5%
Antiemetics4 products · 3%
Antifungals4 products · 3%
Formulation footprint

Dosage forms

Tablet60 products
Injection27 products
Capsule10 products
Cream6 products
Infusion6 products
Suspension5 products
Solution3 products
Drops2 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 CefsureCeftriaxone 10presentations 1 g, 2 g, 250 mg, 500 mg · Injection #2 TamlevLevetiracetam 7presentations 100 mg/mL, 250 mg, 500 mg/5 mL, 750 mg · Solution, Tablet, Injection #3 AmesureCiprofloxacin 4presentations 200 mg/100 mL, 250 mg, 500 mg, 750 mg · Infusion, Tablet #4 ClarocinClarithromycin 4presentations 125 mg/5 mL, 250 mg, 500 mg · Drops, Tablet, Infusion #5 QuopineQuetiapine 4presentations 100 mg, 200 mg, 25 mg, 300 mg · Tablet #6 SuresefCefotaxime 4presentations 1 g, 2 g, 250 mg, 500 mg · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median9384% of comparable products
Near market median11within ±5% of median
Above market median76% of comparable products
Lowest-price equivalents14ties included
Company median price position -20.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Ylenol 500 mgParacetamol · Tablet · 10 x 10's PKR 0.80/tablet-78.1% vs market median Penicillamine D-Penicillamine … 250 mgPenicillamine · Tablet · 10's PKR 23.22/tablet-76.7% vs market median Lifsave 0.5 mgNitroglycerin · Tablet · 3 x 10's PKR 0.47/tablet-63.5% vs market median Clarocin 500 mgClarithromycin · IV infusion · 1's PKR 123.85/vial/unit-60.5% vs market median Biofloxacin 400 mgMoxifloxacin · Tablet · 1 x 5's PKR 77.41/tablet-58.0% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 40shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 39shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 37shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 35shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 35shared generics Epharm Laboratories144 products · 67 generics 35shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers110Distinct registrations among indexed, published, presentation-validated products only
Verified price observations120
Products with a verified price120
Products with multiple price observations0
Source records with multiple versions117
Latest portfolio source check22 Sep 2026
Latest effective price date21 Oct 2025
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

113 unique registration(s) · 120 indexed presentation(s) · 3 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Amesure Ciprofloxacin 250 mg Tablet 10's 048447 PKR 201.26 PKR 20.13/tablet 21% below median
Amesure Ciprofloxacin 500 mg Tablet 10's 048448 PKR 332.84 PKR 33.28/tablet 22% below median
Amesure Ciprofloxacin 750 mg Tablet 10's 048449 PKR 356.06 PKR 35.61/tablet 11% below median
Amesure Ciprofloxacin 200 mg/100 mL IV infusion 1*100ml Vial` 073517 PKR 154.81 — No comparator
AmesureSource observed Ciprofloxacin 0.3 % Held for normalizationSource reported: Tablet · structural field conflict 5ml 075898Official source ↗ No indexed price — —
AmesureSource observed Ciprofloxacin 0.3 % Held for normalizationSource reported: Tablet · structural field conflict 5ml 075899Official source ↗ No indexed price — —
Ascor-C Ascorbic acid 500 mg Tablet 4*10's 104359 PKR 46.44 PKR 1.16/tablet 24% below median
Aztrix Azithromycin 250 mg Capsule 10's 067242 PKR 394.77 PKR 39.48/capsule 20% below median
Aztrix Azithromycin 200 mg/5 mL Suspension 15ml 083199 PKR 255.43 PKR 17.03/mL 22% below median
Aztrix Azithromycin 500 mg Tablet 6's 104358 PKR 425.73 PKR 70.96/tablet 16% below median
Biofloxacin Moxifloxacin 400 mg Tablet 1 x 5's 035804 PKR 387.03 PKR 77.41/tablet 58% below median
Cefsure Ceftriaxone 250 mg IV injection 1's 045226 PKR 156.36 PKR 156.36/vial/unit 16% below median
Cefsure Ceftriaxone 500 mg IV injection 1's 045227 PKR 263.18 PKR 263.18/vial/unit 16% below median
Cefsure Ceftriaxone 1 g IV injection 1's 045228 PKR 496.94 PKR 496.94/vial/unit 20% below median
Cefsure Ceftriaxone 500 mg Injection 1's 092828 PKR 263.18 PKR 263.18/vial/unit 20% below median
Cefsure Ceftriaxone 1 g Injection 1's 092829 PKR 496.94 PKR 496.94/vial/unit 18% below median
Cefsure Ceftriaxone 250 mg Injection 1's 092830 PKR 156.36 PKR 156.36/vial/unit 19% below median
Cefsure Ceftriaxone 250 mg Injection 1's 096858 PKR 156.36 PKR 156.36/vial/unit 19% below median
Cefsure Ceftriaxone 500 mg IM injection 1's 096859 PKR 263.18 PKR 263.18/vial/unit 20% below median
Cefsure Ceftriaxone 1 g IM injection 1's 096860 PKR 496.94 PKR 496.94/vial/unit 20% below median
Cefsure Ceftriaxone 2 g IV injection 1'S 107394 PKR 696.65 PKR 696.65/vial/unit 19% below median
Ceftazime Ceftazidime 250 mg Injection 1's 096855 PKR 133.84 PKR 133.84/vial/unit 16% below median
Ceftazime Ceftazidime 500 mg Injection 1's 096856 PKR 203.58 PKR 203.58/vial/unit 16% below median
Ceftazime Ceftazidime 1 g Injection 1's 096857 PKR 382.39 PKR 382.39/vial/unit 17% below median
Cefxin Cefuroxime 750 mg Injection 1's 092655 PKR 154.81 PKR 154.81/vial/unit 19% below median
Cefxin Cefuroxime 250 mg Injection 1's 092656 PKR 43.35 PKR 43.35/vial/unit 20% below median
Chlorosure Chloroquine 250 mg Tablet 50*10's 105566 PKR 614.32 PKR 1.23/tablet 22% below median
Clarocin Clarithromycin 250 mg Tablet 1 x 10's 029236 PKR 464.43 PKR 46.44/tablet Near median
Clarocin Clarithromycin 500 mg Tablet 1 x 10's 031149 PKR 820.50 PKR 82.05/tablet Near median
Clarocin Clarithromycin 125 mg/5 mL Oral drops 60ml 032033 PKR 309.62 PKR 5.16/mL 33% below median
Clarocin Clarithromycin 500 mg IV infusion 1's 080301 PKR 123.85 PKR 123.85/vial/unit 61% below median
Clopirato Metoclopramide 10 mg/2 mL Injection 2ml 115953 PKR 30.96 PKR 15.48/mL 20% above median
Colaxsure Bisacodyl 5 mg Tablet 10 x 10's 055599 PKR 47.74 PKR 0.48/tablet 14% below median
Evaxosure Levofloxacin 250 mg Tablet 10's 044249 PKR 387.03 PKR 38.70/tablet 20% below median
Evaxosure Levofloxacin 500 mg Tablet 10's 044250 PKR 644.01 PKR 64.40/tablet 19% below median
Fungista Clotrimazole 1 % Cream 10gm 032809 PKR 77.41 PKR 7.74/g 25% above median
Glaze Gliclazide 80 mg Tablet 30's 029244 PKR 278.66 PKR 9.29/tablet 18% below median
Herpex Aciclovir 5 % Cream 10gm 039473 PKR 263.18 PKR 26.32/g 25% below median
Imperocin Mupirocin 20 mg Cream 15gm 089236 PKR 170.30 PKR 11.35/g 26% below median
IsIs Doxycycline 100 mg Tablet 10 x 10's 029237 PKR 774.05 PKR 7.74/tablet Near median
IsIs Doxycycline 100 mg Capsule 10 x 10's 029238 PKR 774.05 PKR 7.74/capsule Near median
Kanflam Ibuprofen 400 mg Tablet 25 x 10's 029245 PKR 604.77 PKR 2.42/tablet 31% below median
Lactusure Lactulose 3.35 g Syrup 120ml 058250 PKR 168.74 PKR 1.41/mL 40% below median
Lifsave Nitroglycerin 0.5 mg Tablet 3 x 10's 039312 PKR 14.17 PKR 0.47/tablet 63% below median
Lipigan Atorvastatin 10 mg Tablet 10's 032267 PKR 325.11 PKR 32.51/tablet 18% above median
Lipigan Atorvastatin 20 mg Tablet 10's 032268 PKR 617.69 PKR 61.77/tablet 32% above median
Lisibitor Lisinopril 10 mg Tablet 10's 110481 PKR 126.53 PKR 12.65/tablet 36% below median
Longtel Lamotrigine = 100 mg Tablet 3 x 10's 032261 PKR 2,476.95 PKR 82.57/tablet 140% above median
Longtel Lamotrigine = 25 mg Tablet 3 x 10's 035585 PKR 464.43 PKR 15.48/tablet 27% below median
Longtel Lamotrigine = 50 mg Tablet 3 x 10's 035586 PKR 619.24 PKR 20.64/tablet 25% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Medisure Laboratories Pakistan Pvt Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.